These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35271617)

  • 1. Disparities in the quality of care for chronic hepatitis C among Medicare beneficiaries.
    Tran L; Jung J; Feldman R; Riley T
    PLoS One; 2022; 17(3):e0263913. PubMed ID: 35271617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial/Ethnic and Socioeconomic Disparities in Use of Direct-Acting Antivirals Among Medicare Beneficiaries with Chronic Hepatitis C, 2014-2016.
    Jung J; Du P; Feldman R; Kong L; Riley T
    J Manag Care Spec Pharm; 2019 Nov; 25(11):1236-1242. PubMed ID: 31663464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial-Ethnic Disparities in Uptake of New Hepatitis C Drugs in Medicare.
    Jung J; Feldman R
    J Racial Ethn Health Disparities; 2017 Dec; 4(6):1147-1158. PubMed ID: 27928769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodeficiency virus infection.
    Ioannou GN; Bryson CL; Weiss NS; Miller R; Scott JD; Boyko EJ
    Hepatology; 2013 Jan; 57(1):249-57. PubMed ID: 22532055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial disparities in clinical presentation, surgical procedures, and hospital outcomes among patients with hepatocellular carcinoma in the United States.
    Chikovsky L; Kutuk T; Rubens M; Balda AN; Appel H; Chuong MD; Kaiser A; Hall MD; Contreras J; Mehta MP; Kotecha R
    Cancer Epidemiol; 2023 Feb; 82():102317. PubMed ID: 36566577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can Telementoring Reduce Urban-Rural Disparities in Utilization of Direct-Acting Antiviral Agents?
    Du P; Wang X; Kong L; Jung J
    Telemed J E Health; 2021 May; 27(5):488-494. PubMed ID: 32882154
    [No Abstract]   [Full Text] [Related]  

  • 7. Independent Predictors of Mortality and Resource Utilization in Viral Hepatitis Related Hepatocellular Carcinoma.
    Golabi P; Jeffers T; Younoszai Z; Otgonsuren M; Sayiner M; Mishra A; Venkatesan C; Younossi ZM
    Ann Hepatol; 2017; 16(4):555-564. PubMed ID: 28611258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis.
    Yang JD; Mohamed HA; Cvinar JL; Gores GJ; Roberts LR; Kim WR
    Am J Gastroenterol; 2016 Nov; 111(11):1573-1580. PubMed ID: 27527741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance factors change outcomes in patients with hepatocellular carcinoma due to chronic hepatitis C virus infection in New Zealand.
    Schauer C; van Rijnsoever M; Gane E
    J Viral Hepat; 2019 Dec; 26(12):1372-1376. PubMed ID: 31323163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Race/Ethnicity-Specific Outcomes Among Chronic Hepatitis C Virus Patients Listed for Liver Transplantation.
    Ahn J; Liu B; Bhuket T; Wong RJ
    Dig Dis Sci; 2017 Apr; 62(4):1051-1057. PubMed ID: 28168576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and challenges of liver diseases in patients with chronic hepatitis C virus infection.
    Jacobson IM; Davis GL; El-Serag H; Negro F; Trépo C
    Clin Gastroenterol Hepatol; 2010 Nov; 8(11):924-33; quiz e117. PubMed ID: 20713178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. Veterans with HCV.
    Kanwal F; Kramer JR; Ilyas J; Duan Z; El-Serag HB
    Hepatology; 2014 Jul; 60(1):98-105. PubMed ID: 24615981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States.
    Davila JA; Henderson L; Kramer JR; Kanwal F; Richardson PA; Duan Z; El-Serag HB
    Ann Intern Med; 2011 Jan; 154(2):85-93. PubMed ID: 21242365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection.
    Kanwal F; Hoang T; Kramer JR; Asch SM; Goetz MB; Zeringue A; Richardson P; El-Serag HB
    Gastroenterology; 2011 Apr; 140(4):1182-1188.e1. PubMed ID: 21184757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Immunodeficiency Virus/Hepatitis C Virus (HCV) Co-infected Patients With Cirrhosis Are No Longer at Higher Risk for Hepatocellular Carcinoma or End-Stage Liver Disease as Compared to HCV Mono-infected Patients.
    Salmon-Ceron D; Nahon P; Layese R; Bourcier V; Sogni P; Bani-Sadr F; Audureau E; Merchadou L; Dabis F; Wittkop L; Roudot-Thoraval F;
    Hepatology; 2019 Sep; 70(3):939-954. PubMed ID: 30569448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Joint replacement surgeries among medicare beneficiaries in rural compared with urban areas.
    Francis ML; Scaife SL; Zahnd WE; Cook EF; Schneeweiss S
    Arthritis Rheum; 2009 Dec; 60(12):3554-62. PubMed ID: 19950278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing Urban-Rural Disparities in the Utilization of Direct-Acting Antiviral Agents for Hepatitis C in U.S. Medicare Patients, 2014-2017.
    Du P; Wang X; Kong L; Riley T; Jung J
    Am J Prev Med; 2021 Feb; 60(2):285-293. PubMed ID: 33221144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of racial/ethnic and etiology/disease-specific factors is associated with lower survival following liver transplantation in African Americans: an analysis from UNOS/OPTN database.
    Wong RJ; Ahmed A
    Clin Transplant; 2014 Jul; 28(7):755-61. PubMed ID: 24750171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of end stage liver disease and hepatocellular carcinoma among persons infected with hepatitis C virus: publication bias?
    Goodgame B; Shaheen NJ; Galanko J; El-Serag HB
    Am J Gastroenterol; 2003 Nov; 98(11):2535-42. PubMed ID: 14638360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia.
    Alavi M; Law MG; Valerio H; Grebely J; Amin J; Hajarizadeh B; Selvey C; George J; Dore GJ
    J Hepatol; 2019 Aug; 71(2):281-288. PubMed ID: 31078544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.